[1]邱君旗.幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析[J].医学信息,2018,31(04):75-77.[doi:10.3969/j.issn.1006-1959.2018.04.024]
　QIU Jun-qi.Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia[J].Journal of Medical Information,2018,31(04):75-77.[doi:10.3969/j.issn.1006-1959.2018.04.024]
点击复制

幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年04期
页码:
75-77
栏目:
论著
出版日期:
2018-02-15

文章信息/Info

Title:
Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia
文章编号:
1006-1959（2018）04-0075-03
作者:
邱君旗
浙江省平阳县人民医院消化内科，浙江 平阳 325400
Author(s):
QIU Jun-qi
Department of Digestive Medicine,People's Hospital of Pingyang County,Pingyang 325400,Zhejiang,China
关键词:
幽门螺杆菌根除; 功能性消化不良; 四联疗法; 不良反应
Keywords:
Key words：Helicobacter pylori eradication; Functional dyspepsia; Tetralogy; Adverse reactions
分类号:
R57
DOI:
10.3969/j.issn.1006-1959.2018.04.024
文献标志码:
A
摘要:
目的 探讨幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良（FD）患者疗效。方法 选取2015年1月~2017年1月在本院就诊的幽门螺杆菌阳性的功能性消化不良患者82例，随机分为观察组和对照组。对照组40例采取常规药物（莫沙必利+奥美拉唑）治疗，观察组42例采取四联疗法（兰索拉唑+阿莫西林+克拉霉素+胶体次枸橼酸铋）杀灭幽门螺杆菌治疗，比较两组患者症状改善、临床疗效和不良反应发生情况。结果 两组患者治疗后临床症状积分较治疗前均明显降低，观察组治疗后临床症状积分为（2.71±1.86）分，低于对照组的（8.45±1.92）分，差异有统计学意义（P＜0.05）；观察组不良反应发生率（11.90%）明显低于对照组（22.50%），差异有统计学意义（P＜0.05）；观察组总有效率（92.86%）明显高于对照组（75.00%），差异有统计学意义（P＜0.05）。结论 对于幽门螺杆菌阳性的功能性消化不良患者而言，采取四联疗法杀灭幽门螺杆菌，能更加明显改善其临床症状，提高治疗效果，减少不良反应情况，具有临床推广应用价值。
Abstract:
Abstract：Objective To investigate the efficacy of Helicobacter pylori eradication therapy in the treatment of Helicobacter pylori positive patients with functional dyspepsia(FD).Methods From January 2015 to January 2017,82 patients with Helicobacter pylori positive functional dyspepsia were selected.They were randomly divided into observation group and control group.40 patients in the control group were treated with conventional drugs(mosapride+omeprazole).42 patients in the observation group were treated with tetralogy (lansoprazole+amoxicillin+clarithromycin+colloidal bismuth subcitrate)to kill Helicobacter pylori and make comparison of symptom improvement, clinical efficacy and adverse reactions between the two groups.Results The score of clinical symptom in both groups after treatment was significantly lower than that before treatment,and the clinical symptom score in the observation group was(2.71±1.86)points lower than that in the control group(8.45±1.92),the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group(11.90%)was significantly lower than that in the control group(22.50%),the difference was statistically significant(P<0.05).The total effective rate(92.86%)in the observation group was significantly higher than that in the control group(75.00%),the difference was statistically significant(P<0.05).Conclusion For Helicobacter pylori positive functional dyspepsia patients, taking quadruple therapy to kill Helicobacter pylori can more obviously improve its clinical symptoms,improve the therapeutic effect and reduce the adverse reactions, and has clinical application value.

参考文献/References:

[1]曾雪萍.根除幽门螺杆菌治疗顽固性功能性消化不良的疗效观察[J].江西医药,2012,47(06):512-514.
[2]尹庆娜.探讨功能性消化不良及其临床分型与幽门螺杆菌感染的关系[J].中国实用医药,2017,12(8):108-109.
[3]Du L J,Chen B R,Kim J J,et al.Helicobacter pylori eradication therapy for functional dyspepsia:Systematic review and meta-analysis[J].World J Gastroenterol,2016,22(12):3486-3495.
[4]张娜,鹿博.对Hp阳性的功能性消化不良患者行根除Hp治疗的疗效分析[J].现代医学,2013,41(10):748-750.
[5]邹文,范洪波,黄芳.幽门螺杆菌的根除与功能性消化不良症状改善的分析[J].临床医药文献杂志:电子版,2016,3(14):2772.
[6]娄朝晅.柴胡桂枝汤加减治疗功能性消化不良疗效观察[J].山东医药,2013,53(32):72-73.
[7]寇会玲,宗立永,王静.四联疗法根除初治患者幽门螺杆菌疗效观察[J].中国社区医师,2017,33(11):57.
[8]喻英明,黄粤苏.根除幽门螺杆菌及药物治疗对功能性消化不良影响的研究[J].中国伤残医学,2015,23(17):111-112.
[9]冯群,赵庆华,李明杰,等.兰索拉唑药理与毒理研究进展[J].中国药物评价,2014,31(6):378-380.
[10]郭慧.阿莫西林的药理学机制及其在临床中的应用[J].求医问药:学术版,2012,10(2):628.

相似文献/References:

[1]叶 钧,魏雪梅,陈 陵,等.体表胃起搏治疗顽固性胃功能性消化不良的临床效果观察[J].医学信息,2018,31(11):8.[doi:10.3969/j.issn.1006-1959.2018.11.003]
　YE Jun,WEI Xue-mei,CHEN Ling,et al.Clinical Effect of Body Surface Gastric Pacing on Intractable Gastric Functional Dyspepsia[J].Journal of Medical Information,2018,31(04):8.[doi:10.3969/j.issn.1006-1959.2018.11.003]
[2]陈仙梅,于晓兵,董 琳,等.肠易激综合征与功能性消化不良患者症状重叠分析[J].医学信息,2018,31(17):75.[doi:10.3969/j.issn.1006-1959.2018.17.022]
　CHEN Xian-mei,YU Xiao-bing,DONG Lin,et al.Overlapping Analysis of Symptoms in Patients with Irritable Bowel Syndrome and Functional Dyspepsia[J].Journal of Medical Information,2018,31(04):75.[doi:10.3969/j.issn.1006-1959.2018.17.022]
[3]曹火留,张 璋,黄学勤.黛力新联合维生素B6治疗伴负性情绪的功能性消化不良临床疗效研究[J].医学信息,2018,31(22):60.[doi:10.3969/j.issn.1006-1959.2018.22.017]
　CAO Huo-liu,ZHANG Zhang,HUANG Xue-qin.Efficacy of Deanxit and VitB6 tablets in management of negative emotions in patients with Functional dyspepsia[J].Journal of Medical Information,2018,31(04):60.[doi:10.3969/j.issn.1006-1959.2018.22.017]
[4]宋立君,张国梁.枸橼酸莫沙必利联合黛力新治疗功能性消化不良的效果[J].医学信息,2019,32(19):151.[doi:10.3969/j.issn.1006-1959.2019.19.049]
　SONG Li-jun,ZHANG Guo-liang.Effect of Mosapride Citrate Combined with Dailixin in Treating Functional Dyspepsia[J].Journal of Medical Information,2019,32(04):151.[doi:10.3969/j.issn.1006-1959.2019.19.049]
[5]周建祥.多潘立酮联合阿米替林治疗功能性消化不良的疗效及其对胃动力学的影响[J].医学信息,2019,32(23):138.[doi:10.3969/j.issn.1006-1959.2019.23.041]
　ZHOU Jian-xiang.Efficacy of Domperidone Combined with Amitriptyline in the Treatment of Functional Dyspepsia and Its Effect on Gastric Dynamics[J].Journal of Medical Information,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.23.041]
[6]彭小花.护理干预对功能性消化不良患者睡眠质量和消化系统症状的影响[J].医学信息,2020,33(10):185.[doi:10.3969/j.issn.1006-1959.2020.10.058]
　PENG Xiao-hua.Effect of Nursing Intervention on Sleep Quality and Digestive System Symptoms in Patients with Functional Dyspepsia[J].Journal of Medical Information,2020,33(04):185.[doi:10.3969/j.issn.1006-1959.2020.10.058]
[7]黄振鹏.重视饮食管理在功能性胃肠病治疗中的作用和地位[J].医学信息,2021,34(14):1.[doi:10.3969/j.issn.1006-1959.2021.14.001]
　HUANG Zhen-peng.Emphasis on the Role and Status of Diet Management in the Treatment of Functional Gastrointestinal Disorder[J].Journal of Medical Information,2021,34(04):1.[doi:10.3969/j.issn.1006-1959.2021.14.001]
[8]朱小进.米曲菌胰酶片联合莫沙必利治疗老年患者功能性消化不良的效果[J].医学信息,2021,34(14):7.[doi:10.3969/j.issn.1006-1959.2021.14.003]
　ZHU Xiao-jin.Effect of Oryz-Aspergillus Enzyme and Pancreatin Tablet Combined with Mosapride on Functional Dyspepsia in Elderly Patients[J].Journal of Medical Information,2021,34(04):7.[doi:10.3969/j.issn.1006-1959.2021.14.003]
[9]方 宁,李仁君.抑郁症患者FD、IBS以及FD合并IBS患病情况分析[J].医学信息,2022,35(03):124.[doi:10.3969/j.issn.1006-1959.2022.03.031]
　FANG Ning,LI Ren-jun.Analysis of FD, IBS and FD with IBS in Depression Patients[J].Journal of Medical Information,2022,35(04):124.[doi:10.3969/j.issn.1006-1959.2022.03.031]
[10]胡黎黎.胃肠安丸联合三联疗法治疗儿童功能性消化不良伴Hp阳性的疗效及对胃肠动力的影响[J].医学信息,2023,36(17):138.[doi:10.3969/j.issn.1006-1959.2023.17.028]
　HU Li-li.Efficacy of Weichang’an Pills Combined with Triple Therapy in the Treatment of Functional Dyspepsia with Hp Positive in Children and its Effect on Gastrointestinal Motility[J].Journal of Medical Information,2023,36(04):138.[doi:10.3969/j.issn.1006-1959.2023.17.028]

更新日期/Last Update: 2018-02-15